Benjamin Kahlert, Michael Rückert, Azzaya Sengedorj, Konstantin Root, Martin Wadepohl, Rainer Fietkau, Katia Parodi, Udo S Gaipl, Christoph Bert, Benjamin Frey
This work substantially narrows
the gap towards an accessible, easy-to-use small-animal hyperthermia applicator and
provides the base-validation needed before progressing to in vivo experiments.
OBJECTIVE: The design and base-validation of a small-animal microwave
hyperthermia applicator for the adaptation of the clinically used BSD-500
hyperthermia device to function with mice.
APPROACH: We iteratively designed and
tested a 3D-printable applicator, using mouse cadavers as well as the life sciences
simulation software Sim4life to optimise the applicator. The applicator uses an agarose
phantom to couple the antenna to the tissue, and we determined the dielectric and
thermal properties thereof. To monitor the temperatures in the cadavers during
the experiments, electromagnetically stable 4-wire sensors from the clinical device
were read out independently.
MAIN RESULTS: The agarose coupling phantom was
characterised dielectrically and thermally and closely approximated muscle tissue
(ϵr = 51.91, σ = 0.99Sm-1 at 915MHz) and cp = (2592 ± 40)Jkg-1K-1. The
independent sensor readout achieved 3Hz data collection with a sensor standard
deviation from the reference thermometer smaller than 0.01◦C. In each of the
validation experiments visual positioning was by itself sufficient to ensure the tumour-
surrogate reached therapeutic temperatures (40 ◦C-43◦C) using only a control sensor
in the agarose gel in contact with the mouse body. Extrapolating from our data, the
highest temperature should occur in the gel at the antenna tip, reaching approximately
43◦C. The therapeutic zone extends to a depth of 9.3mm to 17.6mm (95% CI). The
electromagnetic simulation predicted the heating-rate distribution well and was robust
to changes in material properties and problem geometry. Perfusion-aware simulations
based on the Pennes bioheat equation predicted at most an ≈21% reduction in tumour
heating under physiological conditions, indicating that therapeutic temperatures
should remain achievable in vivo.
SIGNIFICANCE: This work substantially narrows
the gap towards an accessible, easy-to-use small-animal hyperthermia applicator and
provides the base-validation needed before progressing to in vivo experiments.